openPR Logo
Press release

Top Market Shifts Transforming the Immunoglobulins Market Landscape: Key Insights

09-12-2025 08:02 AM CET | Health & Medicine

Press release from: The Business Research Company

Immunoglobulins

Immunoglobulins

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Immunoglobulins Market Through 2025?
The market size of immunoglobulins has seen a strong increase in the recent past. The projected growth sees it scaling up from $18.85 billion in 2024 to $20.32 billion by 2025, with a compound annual growth rate (CAGR) of 7.8%. The historical period growth is attributable to factors such as a rise in immunodeficiency disorders, an increase in the elderly population, higher utilization of immunoglobulins in hospitals, supportive government reimbursement policies, as well as an increased occurrence of chronic and autoimmune diseases.

What's the Projected Size of the Global Immunoglobulins Market by 2029?
The immunoglobulins market is set for a robust growth spurt in the coming years, with an expected size of "$30.89 billion by 2029," demonstrating a compound annual growth rate (CAGR) of 11.0%. This surge during the forecast period is largely due to increased investment into the development of cutting-edge technologies, a rising understanding of immunodeficiency treatments, a growing preference among medical professionals for these treatments, the rise of new markets, and the broadening of applications into the realms of sports and fitness. Significant trends moving into this forecast period include the creation of wearable and intelligent compression devices, bespoke compression therapy solutions, the blending of compression therapy with wound care management, a focus on patient comfort and compliance within the realm of compression therapy, and strategic collaborations between manufacturers and healthcare providers to enhance patient results.

View the full report here:
https://www.thebusinessresearchcompany.com/report/immunoglobulins-global-market-report

Top Growth Drivers in the Immunoglobulins Industry: What's Accelerating the Market?
The growth of the immunoglobulins market is influenced by the escalating elderly population. This segment of the population is significantly prone to infectious and autoimmune diseases. The functionality of the immunoglobulin test lies in its capacity to measure the body's ability to generate antibodies, which shield against bacteria, viruses, and allergies. For instance, a World Health Organization (WHO) report from October 2022 projected that one in six people worldwide would be 60 or above by 2030. Moreover, by 2050, the number of people aged 60 or above globally will reach 2.1 billion. Consequently, the escalating number of elderly individuals is anticipated to enhance the demand for the immunoglobulins market in the future.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5284&type=smp

What Are the Key Trends Driving Immunoglobulins Market Growth?
Top-tier firms in the immunoglobulins industry are innovating and offering products like intravenous immunoglobulins with the objective of expanding their customer reach and boosting their profits. A case in point is the release of ALYGLOTM (Immune Globulin Intravenous, Human-stwk) 10% Liquid by GC Biopharma, a biotech business based in South Korea, in September 2024 for the U.S market. It is designed specifically for adults 17 years and older who suffer from primary humoral immunodeficiency (PI) and can be accessed via specialised pharmacies. With the U.S. being the largest international market for immunoglobulin with an approximate value of $11.6 billion, this launch holds immense potential. GC Biopharma's goal for ALYGLO's first-year sales is set at $50 million, with a long-term objective to raise this number to $300 million by the year 2028. An essential element of their aggressive growth map includes forming alliances with major U.S. pharmacy benefit managers and specialty pharmacies, given their pivotal role in the efficient distribution of immunoglobulin products.

What Are the Main Segments in the Immunoglobulins Market?
The immunoglobulins market covered in this report is segmented -

1) By Product: IGG, IGA, IGM, IGE, IGD.
2) By Mode Of Delivery: Intravenous Mode Of Delivery, Subcutaneous Mode Of Delivery
3) By Application: Hypogammaglobulinemia, Chronic Inflammatory demyelinating polyneuropathy (CIDP), Immunodeficiency Disease, Myasthenia Gravis, Idiopathic thrombocytopenic purpura (ITP), Other Applications

Subsegments:
1) By IGG (Immunoglobulin G): IVIG (Intravenous Immunoglobulin), SCIG (Subcutaneous Immunoglobulin)
2) By IGA (Immunoglobulin A): Monoclonal IGA, Polyvalent IGA
3) By IGM (Immunoglobulin M): Monoclonal IGM, Polyvalent IGM
4) By IGE (Immunoglobulin E): Allergen-Specific IGE, Monoclonal IGE
5) By IGD (Immunoglobulin D): Research-Use IGD, Monoclonal IGD

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=5284&type=smp

Which Top Companies are Driving Growth in the Immunoglobulins Market?
Major companies operating in the immunoglobulins market include Baxter International Inc., CSL Behring LLC, Grifols S. A., Octapharma AG, China Biologic Products Holdings Inc., Kedrion SpA, LFB SA, Biotest AG, Sanquin Blood Supply Foundation, ADMA Biologics Inc., Option Care Health Inc., Shanghai RAAS Blood Products Co. Ltd., Antibody Solutions, Bio Products Laboratory Ltd., Immunovant Inc., Kamada Ltd., Emergent BioSolutions Inc., Fresenius Kabi AG, GlaxoSmithKline plc, Pfizer Inc., Roche Holding AG, Samsung Bioepis Co. Ltd., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Zydus Cadila Healthcare Limited

Which Regions Will Dominate the Immunoglobulins Market Through 2029?
North America was the largest region in the immunoglobulins market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the immunoglobulins market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5284

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795,
Asia +44 7882 955267 & +91 8897263534,
Europe +44 7882 955267
Email:saumyas@tbrc.info
The Business Research Company -www.thebusinessresearchcompany.com
Follow Us On:
LinkedIn:https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Top Market Shifts Transforming the Immunoglobulins Market Landscape: Key Insights here

News-ID: 4180236 • Views:

More Releases from The Business Research Company

Segment Evaluation and Major Growth Areas in the Personalized Testing and Supplements Market
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future. Market Valuation and Expansion Forecast for Personalized Testing
Top Players and Market Competition in the Skin Microbiome Industry
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry. Projected Expansion in the Skin
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market Landscape
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory. Steady Growth Expected in Upadacitinib Market Size Through 2029 The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Market
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field. Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics

All 5 Releases


More Releases for Immunoglobulin

Immunoglobulin Market Forecast 2035 | Advancing Therapeutic Outcomes: Growth of …
An extensive study of propelling opportunities in, "Immunoglobulin Market Size, Share & Trends Analysis Report by Product Type (IgG, IgA, IgM, IgE, IgD), Form, Route of Administration, Application, Source, Technology, Therapy Type, Patient Demographics, End-user / Distribution Channel and Geography (North America, Europe, Asia Pacific, Middle East, Africa, and South America) - Global Industry Data, Trends, and Forecasts, 2025-2035" A comprehensive report of growing market landscapes in the immunoglobulin sector
Rabies Immunoglobulin Market - Dynamics and Growth Pattern
The "Rabies Immunoglobulin Market" forecast 2031 report analyses the present and future competitive scenario of the analytics industry. Rabies Immunoglobulin Market report offers an in-depth analysis on segments including top companies, products, applications, revenue and regions. a number of topics including likewise market share, drivers, trends and methods. This report additionally offers insights into the latest growth and trends. It encapsulates key aspects of the market, with focus on leading
Key Subcutaneous Immunoglobulin (SCIG) Market Trend for 2025-2034: Advancements …
What Is the Future Outlook for the Subcutaneous Immunoglobulin (SCIG) Market's Size and Growth Rate? There has been a rapid expansion in the subcutaneous immunoglobulin (SCIG) market size in the previous years. It's projected to swell from $12.72 billion in 2024 to $14.52 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 14.1%. The upsurge in the past era is credited to the heightened occurrence of immunodeficiency disorders,
Intravenous Immunoglobulin Market CAGR of intravenous immunoglobulin market is t …
The report is designed to provide a holistic view of the Intravenous Immunoglobulin Market .It provides the industry overview with market growth analysis with a historical & futuristic perspective for the following parameters; revenue, demands, and supply data (as applicable). Regional estimates and forecasts & trend analysis for eac country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Luxemburg, Rest of Europe, Japan, China, South
Intravenous Immunoglobulin Market CAGR of intravenous immunoglobulin market is t …
The report is designed to provide a holistic view of the Intravenous Immunoglobulin Market . It provides the industry overview with market growth analysis with a historical & futuristic perspective for the following parameters; revenue, demands, and supply data (as applicable). Regional estimates and forecasts & trend analysis for eac country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Luxemburg, Rest of Europe, Japan, China,
Immunoglobulin Market 2021 | Detailed Report
Global Immunoglobulin Market 2021-2027, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market. An exclusive data offered in this report is collected by research and industry experts team. Get Free Sample PDF (including full TOC, Tables and Figures) of